Dear Editor,
In current cancer treatment, fighting against cancer with cytotoxic drug is often
challenged by the emergence of chemotherapy resistance, because the patients are usually
treated by standard protocols without considering individual response to chemotherapy.
1
As a promising field of personalized therapy of cancer, microRNA pharmacogenomics
promotes to understand different individual responses to certain drugs and provides
reasonable reference for clinical treatment.
2, 3
However, it is still lacking comprehensive resource to discover and deposit such chemotherapy
resistance-associated miRSNPs (CRmiRSNPs). Therefore, we constructed an omnibus repository
named CREAM (Chemotherapy ResistancE-Associated MiRSNP), which furnishes a user-friendly
interface for a convenient retrieval of CRmiRSNP. The CREAM is freely available at
http://bioinfo.hrbmu.edu.cn/CREAM/.
In CREAM, two types of CRmiRSNP (SNP that locates in the precursor of microRNA or
3′ UTR of microRNA target gene transcript, in which all these SNP, microRNA or gene
are associated with chemotherapy response for the same compound) were mainly focused
on, because both of these two CRmiRSNPs have been proven to influence the function
of microRNA and may convert a sensible tumor cell into a resistant one by changing
the expression of microRNA or their targets.
2
Through utilizing genomic location and microRNA regulatory information, we have identified
150 CRmiRSNPs (Supplementary Figure 1a) across 1164 compounds from the chemotherapy
response data as well as SNP genotyping, gene expression and microRNA expression profiles
(more details in the ‘Technical Implementation' section of Supplementary Information).
As an efficient search platform, CREAM supports four types of query (including compound,
gene, microRNA and SNP) for a convenient retrieval of each record, which not only
offers the complete details of CRmiRSNP we have discovered, but also extends to display
each compound with the elaborative descriptions and genomic distribution maps of chemotherapy
resistance-associated molecules (including SNP, gene and microRNA). For instance,
an interested compound can be queried to access which miRSNPs, genes, microRNAs and
SNPs are associated with the chemotherapy response of this compound. Additionally,
users can further visualize the chromosomal location and statistical significance
of chemotherapy resistance-associated molecules for the queried compound (Supplementary
Figure 1b). Finally, full entries in CREAM can be easily downloaded for systematic
analysis (more details in the ‘Practical Example' section of Supplementary Information).
Several miRSNP-related databases, centered on miRSNP's location and function, have
been built recently.
4, 5
However, the resource that discovers the link between miRSNP and chemotherapy resistance
has not been reported. The database of CREAM may contribute to systematic analysis
of abundant chemicals (in this version it includes 1164 chemicals) in basic drug discovery,
and the proposed strategy of identifying CRmiRSNP is in favor of precise selection
of proper treatment in clinical cancer therapy. With constant expansion and improvement,
we hope this resource will become a bridge between the laboratory investigation and
clinical practice in the field of chemotherapy resistance research and stimulate further
interest on the role of interactions among multi-level molecules in the individual
chemoresponse network.